Pura Vida Investments’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,479,292
Closed -$5.52M 271
2022
Q1
$5.52M Sell
1,479,292
-152,807
-9% -$721K 0.18% 116
2021
Q4
$10.1M Sell
1,632,099
-46,539
-3% -$278K 0.37% 71
2021
Q3
$9.03M Buy
1,678,638
+226,292
+16% +$1.71M 0.27% 96
2021
Q2
$14M Sell
1,452,346
-174,187
-11% -$1.37M 0.44% 55
2021
Q1
$10.9M Buy
1,626,533
+724,258
+80% +$4.3M 0.31% 67
2020
Q4
$4.59M Hold
902,275
0.17% 109
2020
Q3
$3.23M Hold
902,275
0.17% 105
2020
Q2
$4.02M Sell
902,275
-127,006
-12% -$514K 0.39% 63
2020
Q1
$3.11M Buy
1,029,281
+785,178
+322% +$3.24M 0.37% 58
2019
Q4
$1.29M Buy
+244,103
New +$970K 0.11% 89

Other funds holding STXS

Pura Vida Investments's STXS Position: Q2 2022 in Review

Pura Vida Investments sold out of Stereotaxis (STXS) in Q2 2022, closing a stake of 1,479,292 shares — an estimated $5.52M sold.

Pura Vida Investments first reported a position in STXS in Q4 2019 and held it in 10 quarters. The position peaked at $14M in Q2 2021. 85 funds tracked by Wall St. Rank hold STXS as of Q2 2022.

  • Pura Vida Investments reported no remaining Stereotaxis position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 1,479,292 Stereotaxis shares in Q2 2022, an estimated $5.52M.
  • Pura Vida Investments first reported a position in Stereotaxis in Q4 2019 and held it in 10 quarters.
  • Pura Vida Investments's Stereotaxis position peaked at $14M in Q2 2021.
  • 85 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.